Beyond the Streetlight Effect
An Alternative Path to LP Autonomy in Continuation Vehicles
Professor Claudia Zeisberger raises the Private Equity cycle's defining question: when a GP moves a trophy asset into a Continuation Vehicle (CV), “Do LPs actually understand what they're being offered to roll into?”
As a lead diagnostician, my answer is no—but the “why” offers a fascinating opportunity.
This uncertainty drives severe market friction. Alexandra Heal’s Financial Times report “Private equity investor body sounds alarm on ‘conflict vehicles’” highlights a structural symptom: 80% of LPs cash out of CVs, increasingly viewing them as “conflict vehicles”. Consequently, ILPA is rallying General Partners (GPs) for more “transparency”.
I view this challenge differently. Demanding transparency within the current system mirrors the “Streetlight Effect”—searching for the lost keys under a lamppost simply because that is where the light is.
Here, financial models and GP-authored memos are the lamppost. Limited Partners (LPs) ask GPs to turn up the brightness (transparency). Yet, if an asset’s root-cause contagions lie outside that illuminated circle, brighter engineered metrics will not locate the missing keys.
To see the invisible opportunity, we must assess asset health exactly as a cardiologist examines a patient:
The patient “looks” fine (the GP’s “Trophy Asset” narrative).
The doctor prescribes standard treatment (conventional CV pricing and memos).
The scan exposes undeniable arterial plaque as a percentage, confidently providing a risk assessment (hidden structural decay).
A CAC scan bypasses surface symptoms to measure physical reality. If an asset hides a 29% structural decay beneath its financial façade, asking GPs for better spreadsheets will not uncover it.
A suggestion perhaps is move beyond prescribed guidelines hoping for GP collaboration, and instead explore autonomous PE “CAC Scores”.
LPs could hold such a key today. By running an CAC scan equivalent—using external shadow data to trace operational telemetry—LPs tangibly could calculate invariant health without demanding transparency or GP permission.
Shifting to such autonomy, would open an alternative path for LPs in Continuation Vehicles, without conflict. Independent telemetry evolves LPs into autonomous decision-makers.
To see the impossible, we simply bring a new ruler.
